Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Purpose
著者Fukuoka M, Wu YL, Thongprasert S, Sunpaweravong P, Leong SS, Sriuranpong V, Chao TY, Nakagawa K, Chu DT, Saijo N, Duffield EL, Rukazenkov Y, Speake G, Jiang HY, Armour AA, To KF, Yang JCH, Mok TSK
期刊名稱Journal of Clinical Oncology
詳細描述doi: 10.1200/JCO.2010.31.8162.
出版年份2011
月份7
日期20
卷號29
期次21
出版社AMER SOC CLINICAL ONCOLOGY
頁次2866 - 2874
國際標準期刊號0732-183X
電子國際標準期刊號1527-7755
語言英式英語
Web of Science 學科類別Oncology; ONCOLOGY

上次更新時間 2020-17-10 於 23:48